Carlson Capital’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Carlson Capital’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-200,000	Closed	-$4.82M	–	151
2023 Q1	$4.82M	Buy	+200,000	New	+$2.51M	0.45%	62

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Carlson Capital's PRVB Position: Q2 2023 in Review

Carlson Capital sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 200,000 shares — an estimated $4.82M sold.

Carlson Capital first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $4.82M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Carlson Capital reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Carlson Capital sold 200,000 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $4.82M.
Carlson Capital first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Carlson Capital's Provention Bio, Inc. Common Stock position peaked at $4.82M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Carlson Capital's 13F filing for Q2 2023, filed 10 Aug 2023.